Cecilia Jones - Sep 26, 2022 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Chief Financial Officer
Signature
/s/ William Cook, as attorney-in-fact for Cecilia Jones
Stock symbol
AGIO
Transactions as of
Sep 26, 2022
Transactions value $
$0
Form type
4
Date filed
9/28/2022, 04:10 PM
Previous filing
Mar 3, 2022
Next filing
Mar 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Stock options (right to buy) Award $0 +118K $0.00 118K Sep 26, 2022 Common stock 118K $27.88 Direct F1
transaction AGIO Restricted stock units Award $0 +22.4K $0.00 22.4K Sep 26, 2022 Common stock 22.4K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on September 26, 2022. The shares underlying this option vest as to 25% of the underlying shares on September 26, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3 The restricted stock units were granted on September 26, 2022. Beginning on September 26, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.